Patent · US Active

SGC stimulators

US10189809B2 · kind B2 · utility

0Cited by
8References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 17, 2017
Grant dateJan 29, 2019
Priority date—
Expiry dateFeb 17, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I are described. They are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds may be useful for treating, preventing or managing various disorders that are herein disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.